Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Duan, Kai; Liu, Bende; Li, Cesheng; Zhang, Huajun; Yu, Ting; Qu, Jieming; Zhou, Min; Chen, Li; Meng, Shengli; Hu, Yong; Peng, Cheng; Yuan, Mingchao; Huang, Jinyan; Wang, Zejun; Yu, Jianhong; Gao, Xiaoxiao; Wang, Dan; Yu, Xiaoqi; Li, Li; Zhang, Jiayou; Wu, Xiao; Li, Bei; Xu, Yanping; Chen, Wei; Peng, Yan; Hu, Yeqin; Lin, Lianzhen; Liu, Xuefei; Huang, Shihe; Zhou, Zhijun; Zhang, Lianghao; Wang, Yue; Zhang, Zhi; Deng, Kun; Xia, Zhiwu; Gong, Qin; Zhang, Wei; Zheng, Xiaobei; Liu, Ying; Yang, Huichuan; Zhou, Dongbo; Yu, Ding; Hou, Jifeng; Shi, Zhengli; Chen, Sai‐Juan; Zhu, Chen; Zhang, Xinxin; Yang, Xiaoming

doi:10.1073/pnas.2004168117

Public

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Published in Proceedings of the National Academy of Sciences • Apr 6, 2020

Authors:

Kai Duan

Bende Liu

Cesheng Li

Abstract

Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were enrolled prospectively. One dose of 200 mL of convalescent plasma (CP) derived from recently recovered donors with th...

Subject

Medicine

Viremia

Clinical endpoint

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!